Synthesis, molecular docking, molecular dynamic simulation and biological evaluation of novel 3,4-dihydropyridine derivatives as potent antituberculosis agents.

IF 3.9 2区 化学 Q2 CHEMISTRY, APPLIED
Riya Khandelwal, Mahesh Vasava, Vijay Kevlani, Chintan Parmar, Apurva Prajapati, Hitesh Patel, Paresh Patel
{"title":"Synthesis, molecular docking, molecular dynamic simulation and biological evaluation of novel 3,4-dihydropyridine derivatives as potent antituberculosis agents.","authors":"Riya Khandelwal, Mahesh Vasava, Vijay Kevlani, Chintan Parmar, Apurva Prajapati, Hitesh Patel, Paresh Patel","doi":"10.1007/s11030-025-11276-6","DOIUrl":null,"url":null,"abstract":"<p><p>Antibiotic resistance is an increasing threat to global public health. Developing new antibiotics and alternative treatments is crucial for combating resistant strains and reducing the global health burden. Hence, we synthesized and evaluated the antitubercular potential of dihydropyridine derivatives. A simplified Biginelli condensation method was employed to synthesize novel 3,4-dihydropyrimidine derivatives (4a-4m) via a one-pot three-component reaction using various substituted benzaldehydes. Reaction completion was monitored via thin-layer chromatography. The structures of the compounds were confirmed by FT-IR, mass spectrometry, <sup>1</sup>H NMR, and <sup>13</sup>C NMR spectroscopy, and melting points were determined by differential scanning calorimetry. ADMET screening was performed for all synthesized compounds. Selected compounds were tested for their antibacterial and anti-tubercular activity against gram-positive and gram-negative bacteria. ADMET screening identified eight potential compounds: 4c, 4e, 4f, 4g, 4i, 4j, 4k, and 4m. The literature emphasized DprE1 as a critical target for anti-tubercular activity. Molecular docking studies revealed promising binding affinities for compounds 4g (- 7.67), 4d (- 7.316), 4e (- 7.062), and 4c (- 7.042) against DprE1. Furthermore, to study the binding stability and interaction patterns of protein-ligand complexes, a molecular dynamics simulation was performed. The stability of the protein-ligand complex was confirmed by low protein RMSD values and minimal fluctuations in ligand RMSD, indicating a stable binding pose throughout the 200 ns simulation. These compounds also exhibited significant antibacterial activity against gram-positive and gram-negative bacteria compared to standard drugs. In-vitro antitubercular assays against the H37Rv strain demonstrated moderate to notable efficacy relative to the standard reference drug. The findings suggest that these compounds could serve as promising drug candidates. Further development may lead to their use as effective antituberculosis agents in future research.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Diversity","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1007/s11030-025-11276-6","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

Antibiotic resistance is an increasing threat to global public health. Developing new antibiotics and alternative treatments is crucial for combating resistant strains and reducing the global health burden. Hence, we synthesized and evaluated the antitubercular potential of dihydropyridine derivatives. A simplified Biginelli condensation method was employed to synthesize novel 3,4-dihydropyrimidine derivatives (4a-4m) via a one-pot three-component reaction using various substituted benzaldehydes. Reaction completion was monitored via thin-layer chromatography. The structures of the compounds were confirmed by FT-IR, mass spectrometry, 1H NMR, and 13C NMR spectroscopy, and melting points were determined by differential scanning calorimetry. ADMET screening was performed for all synthesized compounds. Selected compounds were tested for their antibacterial and anti-tubercular activity against gram-positive and gram-negative bacteria. ADMET screening identified eight potential compounds: 4c, 4e, 4f, 4g, 4i, 4j, 4k, and 4m. The literature emphasized DprE1 as a critical target for anti-tubercular activity. Molecular docking studies revealed promising binding affinities for compounds 4g (- 7.67), 4d (- 7.316), 4e (- 7.062), and 4c (- 7.042) against DprE1. Furthermore, to study the binding stability and interaction patterns of protein-ligand complexes, a molecular dynamics simulation was performed. The stability of the protein-ligand complex was confirmed by low protein RMSD values and minimal fluctuations in ligand RMSD, indicating a stable binding pose throughout the 200 ns simulation. These compounds also exhibited significant antibacterial activity against gram-positive and gram-negative bacteria compared to standard drugs. In-vitro antitubercular assays against the H37Rv strain demonstrated moderate to notable efficacy relative to the standard reference drug. The findings suggest that these compounds could serve as promising drug candidates. Further development may lead to their use as effective antituberculosis agents in future research.

新型3,4-二氢吡啶类抗结核药物的合成、分子对接、分子动力学模拟及生物学评价。
抗生素耐药性对全球公共卫生的威胁日益严重。开发新的抗生素和替代疗法对于抗击耐药菌株和减轻全球卫生负担至关重要。因此,我们合成并评价了二氢吡啶衍生物的抗结核潜力。采用简化的Biginelli缩合法,以不同取代苯甲醛为原料,通过一锅三组分反应合成了新型3,4-二氢嘧啶衍生物(4a-4m)。通过薄层色谱法监测反应完成情况。通过FT-IR、质谱、1H NMR、13C NMR等方法确定了化合物的结构,并通过差示扫描量热法测定了化合物的熔点。对所有合成的化合物进行ADMET筛选。所选化合物对革兰氏阳性和革兰氏阴性细菌的抗菌和抗结核活性进行了测试。ADMET筛选鉴定出8种潜在化合物:4c、4e、4f、4g、4i、4j、4k和4m。文献强调DprE1是抗结核活性的关键靶点。分子对接研究表明,化合物4g(- 7.67)、4d(- 7.316)、4e(- 7.062)和4c(- 7.042)与DprE1具有良好的结合亲和力。此外,为了研究蛋白质-配体复合物的结合稳定性和相互作用模式,进行了分子动力学模拟。低蛋白RMSD值和最小配体RMSD波动证实了蛋白质-配体复合物的稳定性,表明在整个200 ns模拟过程中具有稳定的结合姿态。与标准药物相比,这些化合物对革兰氏阳性和革兰氏阴性细菌也表现出显著的抗菌活性。与标准参比药物相比,对H37Rv菌株的体外抗结核试验显示出中等至显著的疗效。研究结果表明,这些化合物可以作为有希望的候选药物。进一步的发展可能会导致它们在未来的研究中作为有效的抗结核药物使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Diversity
Molecular Diversity 化学-化学综合
CiteScore
7.30
自引率
7.90%
发文量
219
审稿时长
2.7 months
期刊介绍: Molecular Diversity is a new publication forum for the rapid publication of refereed papers dedicated to describing the development, application and theory of molecular diversity and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full papers, perspectives, news and reviews dealing with all aspects of the generation of molecular diversity, application of diversity for screening against alternative targets of all types (biological, biophysical, technological), analysis of results obtained and their application in various scientific disciplines/approaches including: combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display libraries; peptides and peptoids; proteins; oligonucleotides; carbohydrates; natural diversity; new methods of library formulation and deconvolution; directed evolution, origin of life and recombination; search techniques, landscapes, random chemistry and more;
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信